Newtyn Management as of June 30, 2023
Portfolio Holdings for Newtyn Management
Newtyn Management holds 46 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Iac Com New (IAC) | 13.4 | $57M | 900k | 62.80 | |
| Cannae Holdings (CNNE) | 9.6 | $41M | 2.0M | 20.21 | |
| G-III Apparel (GIII) | 7.5 | $32M | 1.6M | 19.27 | |
| PAR Technology Corporation (PAR) | 7.0 | $30M | 900k | 32.93 | |
| Ardagh Metal Packaging S A SHS (AMBP) | 6.2 | $26M | 7.0M | 3.76 | |
| Merrimack Pharmaceuticals In Com New | 5.4 | $23M | 1.9M | 12.30 | |
| Spectrum Brands Holding (SPB) | 4.6 | $20M | 250k | 78.05 | |
| Bristow Group (VTOL) | 4.6 | $19M | 674k | 28.73 | |
| City Office Reit (CIO) | 4.0 | $17M | 3.1M | 5.57 | |
| Theravance Biopharma (TBPH) | 4.0 | $17M | 1.6M | 10.35 | |
| Orion Office Reit Inc-w/i (ONL) | 3.6 | $15M | 2.3M | 6.61 | |
| Mbia (MBI) | 2.8 | $12M | 1.4M | 8.64 | |
| Garrett Motion (GTX) | 2.7 | $11M | 1.5M | 7.57 | |
| Galapagos Nv Spon Adr (GLPG) | 2.6 | $11M | 270k | 40.66 | |
| Phathom Pharmaceuticals (PHAT) | 2.3 | $9.8M | 684k | 14.32 | |
| 2seventy Bio Common Stock | 1.8 | $7.5M | 738k | 10.12 | |
| Ni Hldgs (NODK) | 1.6 | $6.8M | 460k | 14.85 | |
| Kodiak Sciences (KOD) | 1.6 | $6.8M | 990k | 6.90 | |
| Tillys Cl A (TLYS) | 1.3 | $5.6M | 800k | 7.01 | |
| Forum Energy Technologies In Note 9.000% 8/0 (Principal) | 1.3 | $5.4M | 5.5M | 0.99 | |
| Destination Xl (DXLG) | 1.3 | $5.4M | 1.1M | 4.90 | |
| Star Hldgs Shs Ben Int (STHO) | 1.1 | $4.8M | 325k | 14.67 | |
| PG&E Corporation (PCG) | 1.1 | $4.6M | 269k | 17.28 | |
| Forum Energy Technologies In (FET) | 1.1 | $4.6M | 180k | 25.59 | |
| Algoma Stl Group (ASTL) | 1.0 | $4.2M | 591k | 7.10 | |
| 89bio (ETNB) | 0.9 | $3.8M | 200k | 18.95 | |
| Cyteir Therapeutics | 0.8 | $3.5M | 1.4M | 2.60 | |
| Pfsweb Com New | 0.8 | $3.4M | 746k | 4.52 | |
| Amplify Energy Corp (AMPY) | 0.6 | $2.7M | 393k | 6.77 | |
| Sensei Biotherapeutics | 0.5 | $2.1M | 1.8M | 1.14 | |
| Wave Life Sciences SHS (WVE) | 0.4 | $1.8M | 500k | 3.64 | |
| Paratek Pharmaceuticals | 0.4 | $1.7M | 764k | 2.21 | |
| Adverum Biotechnologies | 0.4 | $1.6M | 1.0M | 1.59 | |
| Olema Pharmaceuticals (OLMA) | 0.4 | $1.6M | 175k | 9.03 | |
| Bolt Biotherapeutics | 0.3 | $1.3M | 1.0M | 1.28 | |
| Black Diamond Therapeutics (BDTX) | 0.2 | $1.0M | 200k | 5.05 | |
| Aligos Therapeutics | 0.2 | $874k | 900k | 0.97 | |
| Decibel Therapeutics | 0.2 | $770k | 200k | 3.85 | |
| Arca Biopharma (ABIO) | 0.2 | $636k | 313k | 2.03 | |
| Atea Pharmaceuticals (AVIR) | 0.1 | $334k | 89k | 3.74 | |
| Lamb Weston Hldgs (LW) | 0.1 | $248k | 2.2k | 114.95 | |
| Global Business Travel Group Com Cl A (GBTG) | 0.1 | $224k | 31k | 7.23 | |
| Brilliant Acquisition Corp Right 99/99/9999 | 0.0 | $64k | 457k | 0.14 | |
| Arisz Acquisition Corp Right 99/99/9999 | 0.0 | $22k | 250k | 0.09 | |
| Leafly Holdings *w Exp 02/04/202 (LFLYW) | 0.0 | $19k | 635k | 0.03 | |
| Viveon Health Acquisition Right 12/31/2025 | 0.0 | $14k | 250k | 0.06 |
